Trials / Recruiting
RecruitingNCT07184814
Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- China-Japan Friendship Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to identify the clinical features, management pattern and long-term outcomes of patients with pulmonary arteries involvement in Takayasu's arteritis (TAK-PAI).
Detailed description
The present study intends to conduct a prospective analysis of the clinical data in TAK patients in order to: 1. describe the clinical characteristics and current status of multimodal treatment in patients with TAK-PAI, thereby enhancing the understanding of TAK-PAI; 2. to investigate the risk factors for mortality in patients with TAK-PAI, so as to promote early intervention and reduce mortality. 3. explore factors associated with pulmonary hypertention (PH) in patients with TAK-PAI, so as to facilitate the early identification of patients who may develop PH.
Conditions
- Takayasu Arteritis With Pulmonary Artery Involvement
- Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2025-09-22
- Last updated
- 2025-09-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07184814. Inclusion in this directory is not an endorsement.